Table 1.
Characteristics of patients treated with aTSA/rTSA, categorized by chronic preoperative steroid use
| Variable | No Steroid Use | Steroid Use | Standardized Difference* |
|---|---|---|---|
| n | 2,288 | 1,157 | |
| Age (Years) | 68.9 ± 10.4 | 68.1 ± 10.5 | 0.076 |
| Sex (Female) | 1,475 (64.5%) | 797 (68.9%) | 0.093 |
| Race (White) | 1,969 (86.1%) | 934 (80.7%) | 0.147 |
| BMIa | 29.8 ± 6.4 | 30.1 ± 6.9 | 0.045 |
| Functional Status (Dependent) | 81 (3.6%) | 41 (3.6%) | 0.000 |
| Smoker (Within 1 year) | 230 (10.1%) | 127 (11.0%) | 0.030 |
| ASAb Classification Score | 2.7 ± 0.6 | 2.8 ± 0.5 | 0.186 |
| Diabetes | 346 (15.1%) | 182 (15.7%) | 0.017 |
| Hypertension | 1,551 (67.8%) | 776 (67.1%) | 0.015 |
| COPDc | 268 (11.7%) | 167 (14.4%) | 0.082 |
| Dyspnea | 279 (12.2%) | 157 (13.6%) | 0.041 |
| Congestive heart failure | 14 (0.6%) | 18 (1.6%) | 0.098 |
| Bleeding Disorders | 114 (5.0%) | 55 (4.8%) | 0.011 |
| Renal Failure | 24 (1.0%) | 9 (0.8%) | 0.028 |
| Operation Time (Min) | 114.3 ± 46.2 | 106.4 ± 50.5 | 0.169 |
*Standardized difference where < 0.2 was considered small
aBMI = Body Mass Index, bASA = American Society of Anesthesiologists, cCOPD = Chronic obstructive pulmonary disease